Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain

BSE362.7031.55 (+9.53 %)

PREV CLOSE ( ) 331.15

OPEN PRICE ( ) 337.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9068

TODAY'S LOW / HIGH ( )335.00 370.00

52 WK LOW / HIGH ( )282.15 581

NSE363.2530.95 (+9.31 %)

PREV CLOSE( ) 332.30

OPEN PRICE ( ) 333.00

BID PRICE (QTY) 363.25 (272)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 274174

TODAY'S LOW / HIGH( ) 333.00 369.95

52 WK LOW / HIGH ( )281.1 581.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984

Management Info

Rajesh Jain - Chairman Rajesh Jain - Managing Director

Registered Office

Address Ambala - Chandigarh Highway,,,
Lalru,
Punjab-140501

Phone 01762- 505900

Email companysec@panaceabiotec.com

Website www.panaceabiotec.com

Registrars Details

Skyline Financial Services Pvt Ltd

D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi

Listing : BSE, NSE

NEWS

12Nov Panacea Biotec gets Award notification
Panacea Biotec has received an Award notification from Pan American Heal..

12Nov Panacea Biotec gains on getting Award
Panacea Biotec is currently trading at Rs 399.90, up by 3.50 points or 0..

09Oct Panacea Biotec gets LoA worth Rs 127.2
Panacea Biotec has received a Letter of Acceptance (LoA) worth Rs 127.2..

03Oct Panacea Biotec gets LoA worth Rs 315 c
Panacea Biotec has received a letter of award (LoA) worth around $35.65..

03Oct Panacea Biotec informs about receipt
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	-156.4	-152.3
Gross Profit	-209.3	-260.6
Operating Profit	-100.9	96.8999999999996
Net Sales	908.1	3098.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1128.80 (6.39%)	M.Cap ( in Cr)777.96
Amrutanjan Healthcar (BSE) 689.65 (6.38%)	M.Cap ( in Cr)1993.82
Lupin (BSE) 2114.10 (1.62%)	M.Cap ( in Cr)96571.84
Emcure Pharma (BSE) 1439.60 (2.18%)	M.Cap ( in Cr)27289.76
Aurobindo Pharma (BSE) 1193.70 (1.81%)	M.Cap ( in Cr)69330.29

Shareholding Pattern

	PROMOTERS	72.48%
	NON-INSTITUTION	24.66%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

PANACEA BIOTEC LTD.